All Stories

  1. Low Bone Turnover and Decreased Bone Matrix Mineralization at Diagnosis in Children with Acute Lymphoblastic Leukemia
  2. Follow‐up of osteonecrosis in paediatric acute lymphoblastic leukaemia patients treated with the NOPHO ALL2008 protocol
  3. Cognitive performance in young adult women with a history of premature adrenarche
  4. Health-Related Quality of Life of Young Adult Women with a History of Premature Adrenarche
  5. Demographic and disease-related factors impact bone turnover and vitamin D in children with hemato-oncological diseases
  6. Bisphosphonate treatment for skeletal complications in paediatric cancer—Experience from a single tertiary centre
  7. Cardiorespiratory Fitness in Young Adult Women With a History of Premature Adrenarche
  8. Lymphomas in cartilage-hair hypoplasia – A case series of 16 patients reveals advanced stage DLBCL as the most common form
  9. The human cathelicidin hCAP ‐18 in serum of children with haemato‐oncological diseases
  10. Bisphosphonate treatment in children with acute lymphoblastic leukemia and osteonecrosis – radiological and clinical findings in a national cohort
  11. PCOS Features and Steroid Profiles Among Young Adult Women with a History of Premature Adrenarche
  12. Gonadal Failure Is Common in Long-Term Survivors of Childhood High-Risk Neuroblastoma Treated With High-Dose Chemotherapy and Autologous Stem Cell Rescue
  13. Cardiometabolic Risk Profile Among Young Adult Females With a History of Premature Adrenarche
  14. Trajectories of Growth and Serum DHEAS and IGF-1 Concentrations in Girls With a History of Premature Adrenarche: Attenuation of the Phenotype by Adulthood
  15. Polyostotic Fibrous Dysplasia With and Without McCune–Albright Syndrome—Clinical Features in a Nordic Pediatric Cohort
  16. Children with a History of Premature Adrenarche Have Good Health-Related Quality of Life at the Age of 12 Years
  17. Girls with a History of Premature Adrenarche Have Advanced Growth and Pubertal Development at the Age of 12 Years
  18. Skeletal outcome in long-term survivors of childhood high-risk neuroblastoma treated with high-dose therapy and autologous stem cell rescue
  19. Premature Adrenarche - A Common Condition with Variable Presentation
  20. Serum androgen bioactivity is low in children with premature adrenarche
  21. Blood Erythrocyte and Hemoglobin Concentrations in Premature Adrenarche
  22. Polymorphisms of POR, SULT2A1 and HSD11B1 in children with premature adrenarche
  23. Impact of childhood obesity treatment on body composition and metabolic profile
  24. Polymorphism Pro12Ala of PPARG in Prepubertal Children with Premature Adrenarche and Its Association with Growth in Healthy Children
  25. Serum Anti-Müllerian Hormone Concentrations in Prepubertal Girls with and without Premature Adrenarche: The Influence of Body Mass Index
  26. Body Composition and Bone Mineral Density in Children with Premature Adrenarche and the Association ofLRP5Gene Polymorphisms with Bone Mineral Density
  27. Genetic variation of FTO and TCF7L2 in premature adrenarche
  28. Girls with Premature Adrenarche Have Accelerated Early Childhood Growth
  29. LRP5in premature adrenarche and in metabolic characteristics of prepubertal children
  30. Clinical features of early adrenarche
  31. Androgen Receptor Gene CAG Repeat Polymorphism and X-Chromosome Inactivation in Children with Premature Adrenarche
  32. ACTH Receptor Promoter Polymorphism Associates With Severity of Premature Adrenarche and Modulates Hypothalamo-Pituitary-Adrenal Axis in Children
  33. Childhood Metabolic Syndrome and Its Components in Premature Adrenarche
  34. Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R